TAKEDA PHARMACEUTICAL CO LTDTAK财报
NYSE · pharmaceutical industry
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 121.2M | — | 2024-02-06 |
| Sumitomo Mitsui Trust Holdings, Inc. | 5.50% | 87.4M | — | 2024-02-05 |
内部人交易
Net 90d: +$0 · buys $0 / sells $0时间范围:
类型:
身份:
没有符合筛选条件的交易。